Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Linaclotide in Patients With Overlap of Functional Dyspepsia and Constipation-predominant Irritable Bowel Syndrome

NCT05134584 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05134584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05134584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Linaclotide in Patients With Overlap of Functional Dyspepsia and Constipation-predominant Irritable Bowel Syndrome
Lead sponsor
RenJi Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2021
Completion date
February 28, 2022
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation-predominant irritable bowel syndrome, functional dyspepsia